Wall Street Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212K Buy
8,795
+148
+2% +$3.87K 0.11% 116
2026
Q1
$243K Buy
8,647
+103
+1% +$2.74K 0.14% 93
2025
Q4
$213K Buy
8,544
+274
+3% +$6.91K 0.16% 91
2025
Q3
$211K Buy
+8,270
New +$204K 0.15% 92

Other funds holding PFE

Wall Street Financial Group's PFE Position: Q2 2026 in Review

Wall Street Financial Group increased its Pfizer (PFE) stake by 1.7% in Q2 2026, buying an estimated $3.87K and bringing the position to 8,795 shares worth $212K. The position accounts for 0.11% of the portfolio, ranked #116.

Wall Street Financial Group first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. The position peaked at $243K in Q1 2026. 1,189 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Wall Street Financial Group held 8,795 shares of Pfizer worth $212K as of Q2 2026.
  • Wall Street Financial Group bought 148 Pfizer shares in Q2 2026, an estimated $3.87K.
  • Pfizer made up 0.11% of Wall Street Financial Group's portfolio in Q2 2026, its #116 holding.
  • Wall Street Financial Group first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
  • Wall Street Financial Group's Pfizer position peaked at $243K in Q1 2026.
  • 1,189 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Wall Street Financial Group's 13F filing for Q2 2026, filed 14 Jul 2026.